Atalanta Therapeutics

Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
Fierce Biotech
Mon, 01/11/21 - 10:30 am
Atalanta Therapeutics
Biogen
Genentech
F-Prime
neurodegenerative disease